Home » Science & Technology Current Affairs 2024 » Corbevax gets emergency approval for 12-18...

Corbevax gets emergency approval for 12-18 age group by DGCI

The Drugs Controller General of India (DCGI) has approved the Corona Vaccine Biologicals E Ltd's Corbevax for children in the age group of 12 to 18 years.

Sumit Arora Last updated on December 22nd, 2023 02:40 pm Leave a comment

The Drugs Controller General of India (DCGI) has approved the Corona Vaccine Biologicals E Ltd’s Corbevax for children in the age group of 12 to 18 years. Hyderabad-based pharmaceutical company Biological E Ltd said its coronavirus vaccine Corbevax, is also India’s third homegrown vaccine. Bharat Biotech’s Covaxin is being given to children aged 15 to 18 years from January 3.

About the Corbevax:

Corbevax is called a protein subunit and currently, we have an example of the hepatitis B vaccine which is also similarly a protein subunit vaccine. Corbevax and the other vaccine in India, we have Covovax from Serum Institute.

About the Author

Sumit Arora

Author

As a team lead and current affairs writer at Adda247, my role involves researching and creating informative and engaging content aimed at helping candidates prepare for national and state-level competitive government exams. I specialize in delivering insightful articles that keep aspirants updated on the latest current affairs trends and developments. My primary focus is on educational excellence, ensuring that our readers are well-prepared and informed to face their exams with confidence. Through meticulously crafted content, I aim to guide and support candidates in their journey toward success.